News Room

News Releases

Mar. 13, 2023 (PDF/217KB)Corporate

Sumitomo Pharma, Sumitovant Biopharma, and Myovant Sciences Complete the Transaction
Mar. 06, 2023 (PDF/123KB)Licensing

KYORIN and Sumitomo Pharma Enter into License Agreement of Vibegron in Taiwan and Other Asian Countries
Mar. 03, 2023 (PDF/164KB)Finances

Announcement on Impairment Loss and Revision of Dividend Forecast
Mar. 02, 2023 (PDF/197KB)Corporate

Sumitomo Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions
Feb. 22, 2023 (PDF/170KB)Sustainability

Sumitomo Pharma Announces Contributes to the Relief Efforts for the Earthquake in Turkey and Syria
Feb. 07, 2023Finances

Posted Conference Call for Q3 FY2022 [Webcast]
Jan. 31, 2023 (PDF/438KB)Finances

Presentation Material（Third Quarter Financial Results for FY2022）
Jan. 31, 2023 (PDF/451KB)Finances

Supplementary Financial Data (IFRS) for the Third Quarter of the Year Ending March 31, 2023
Jan. 31, 2023 (PDF/509KB)Finances

Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2023 [IFRS]
Jan. 31, 2023 (PDF/200KB)Finances

Sumitomo Pharma Announces Revisions to Its Financial Forecasts

Nov. 01, 2019 (PDF/1,557KB)Corporate

Press Conference Presentation for Definitive Agreement for Strategic Alliance with Roivant Sciences
Oct. 28, 2019 (PDF/926KB)Finances

Press Conference Presentation for Q2 FY2019 (April 1 to September 30, 2019)
Dec. 02, 2013 (PDF/414KB)R&D

Presentation material of press conference (Healios and DSP: Alliance for Japanese market-iPS cell technology into practical use-)